Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA

ABOUT US

图片名称

Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA


Release time:

2018-08-13

Qilu Pharmaceutical announces that Piperacillin Sodium/Tazobactam Sodium for injection manufactured by its subsidiary Qilu Tianhe Pharmaceutical was approved by US FDA on August 13, 2018. The product was already approved in many countries, including the EU, Japan, Australia, Singapore, South Africa, etc.

齐鲁制药有限公司

Tel: +86-531-83127705831277048312770683127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

E mail:export@qilu-pharma.com, FDF@qilu-pharma.com


监督举报

亲爱的合作伙伴:

欢迎举报以下行为!

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话:0531-83126898/55820713/83126871

举报邮箱:qljc@qilu-pharma.com

收信地址:山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线